England Halts Puberty Blockers for Children, Citing Lack of Evidence

Recent studies and reviews highlight the need for caution and a reevaluation of gender-affirming care for transgender youth.

A Dutch study tracking 2,700 children finds that gender dysphoria often diminishes from adolescence to adulthood.
The Cass review in the UK calls for more holistic and cautious approaches to treating gender-related distress in youth.
England's NHS has stopped prescribing puberty blockers to children, following findings of insufficient evidence on their safety and effectiveness.
Detransitioners and experts argue for a shift towards more evidence-based practices in gender-affirming care.
The debate intensifies in the U.S., with calls for similar reviews and a reassessment of current medical practices for transgender youth.